Anti-PHLDB3 monoclonal antibody

Pre-made anti-PHLDB3 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to PHLDB3/PHLDB3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0233-Ab-1/ GM-Tg-hg-IP0233-Ab-2Anti-Human PHLDB3 monoclonal antibodyHuman
GM-Tg-rg-IP0233-Ab-1/ GM-Tg-rg-IP0233-Ab-2Anti-Rat PHLDB3 monoclonal antibodyRat
GM-Tg-mg-IP0233-Ab-1/ GM-Tg-mg-IP0233-Ab-2Anti-Mouse PHLDB3 monoclonal antibodyMouse
GM-Tg-cynog-IP0233-Ab-1/ GM-Tg-cynog-IP0233-Ab-2Anti-Cynomolgus/ Rhesus macaque PHLDB3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0233-Ab-1/ GM-Tg-felg-IP0233-Ab-2Anti-Feline PHLDB3 monoclonal antibodyFeline
GM-Tg-cang-IP0233-Ab-1/ GM-Tg-cang-IP0233-Ab-2Anti-Canine PHLDB3 monoclonal antibodyCanine
GM-Tg-bovg-IP0233-Ab-1/ GM-Tg-bovg-IP0233-Ab-2Anti-Bovine PHLDB3 monoclonal antibodyBovine
GM-Tg-equg-IP0233-Ab-1/ GM-Tg-equg-IP0233-Ab-2Anti-Equine PHLDB3 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0233-Ab-1/ GM-Tg-hg-IP0233-Ab-2; GM-Tg-rg-IP0233-Ab-1/ GM-Tg-rg-IP0233-Ab-2;
GM-Tg-mg-IP0233-Ab-1/ GM-Tg-mg-IP0233-Ab-2; GM-Tg-cynog-IP0233-Ab-1/ GM-Tg-cynog-IP0233-Ab-2;
GM-Tg-felg-IP0233-Ab-1/ GM-Tg-felg-IP0233-Ab-2; GM-Tg-cang-IP0233-Ab-1/ GM-Tg-cang-IP0233-Ab-2;
GM-Tg-bovg-IP0233-Ab-1/ GM-Tg-bovg-IP0233-Ab-2; GM-Tg-equg-IP0233-Ab-1/ GM-Tg-equg-IP0233-Ab-2
Products NameAnti-PHLDB3 monoclonal antibody
Formatmab
Target NamePHLDB3
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-PHLDB3 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0233-Ag-1Recombinant multi-species PHLB3/ PHLDB3 protein


    Target information

    Target IDGM-IP0233
    Target NamePHLDB3
    Gene ID653583,232970,308431,722281,484470,101081098,533145
    Gene Symbol and SynonymsEG232970,Gm10102,PHLDB3,RGD1561121
    Uniprot AccessionQ6NSJ2
    Uniprot Entry NamePHLB3_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000176531
    Target ClassificationN/A

    The target: PHLDB3, gene name: PHLDB3, also named as . Enables enzyme binding activity. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.